Articles & Video
BioProcess International Fall Digital Week 2020
We explore the agenda for the upcoming BioProcess International Fall Digital Week 2020.
BioProcess International | BioProcess Insider
BioProcess International is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics.
Human Monoclonal Antibodies for SARS-CoV-2
We look at single cell technologies for the isolation of human monoclonals, the molecular basis for SARS-CoV-2 neutralization and antibody synergistic exploration.
REPORT: Diversity, Equity and Inclusion in the Life Sciences 2021
Explore the Diversity, Equity and Inclusion in the Life Sciences 2021 report based on an exclusive study of 483 industry professionals.
REPORT: COVID-19 Response in Cell & Gene Therapy Manufacturing 2021
This exclusive report uncovers the major changes in the cell and gene therapy sector during the COVID-19 pandemic.
Developments in ADC Technology: Toxicity and Design Strategies
We examine the latest developments in ADC technology, as discussed by industry leaders at the Antibody Engineering & Therapeutics conference.
Survey: Antibody Engineering & Therapeutics State of the Industry 2021
What has changed in antibody engineering and antibody-based therapeutics over the last year? Tell us your experience in our industry survey.
Report: Oligonucleotide, Peptide, mRNA and Genome Edited Therapeutics State of the Industry 2021
How has the oligonucleotide, peptide, mRNA and genome editing sector transformed over the last year? This industry report provides insight.
eBook: Antibody Discovery, Selection & Screening
This ebook uncovers the latest approaches and emerging tools for therapeutic antibody discovery.
A look back at TIDES Asia Virtual Scientific Forum 2021
We explore the best of on-demand webinars from this year's TIDES Asia Virtual Scientific Forum.
Scaling up manufacturing when it’s needed most
Learn how Thermo Fisher Scientific scaled up raw material manufacturing for mRNA production, leaning on decades of experience.
Survey: Cell & Gene Therapy COVID-19 Response
What changes are happening in the cell and gene therapy sector as a result of the pandemic? Tell us your experience.
Novel Non-cancer Targets for Therapeutic Antibodies
We look at the latest work on developing non-cancer targets for therapeutic antibodies discussed by industry leaders at Antibody Engineering & Therapeutics.
SURVEY: Diversity, Equity and Inclusion in the Life Sciences 2021
Complete our survey on Diversity, Equity and Inclusion in the Life Sciences 2021 to get exclusive early access to the final report.
Post-event Report: Antibody Engineering & Therapeutics Virtual 2020
We look back at highlights of the recent Antibody Engineering & Therapeutics virtual conference.
Post-event Report: Cell & Gene Therapy Bioprocessing & Commercialization 2020
We review the key highlights from the virtual conference, including analysis of the hottest sessions by BioProcess International magazine.
Pharma’s role in maintaining cancer mortality progress during COVID-19
COVID-19 is threatening the progress made in reducing cancer mortality. Pharma has a pivotal role to play in helping patients and providers navigate the new reality of cancer treatment during the pandemic, and beyond.
TIDES Europe Virtual 2020: Post-event Report
This report looks back at the top sessions and features of this year's TIDES Europe Virtual.
BioProcess International 2020 Post-Event Report
Explore the highlights of the BioProcess International 2020 virtual conference in the post-event round-up.
Driving value in the era of biosimilars - What payers & manufacturers can do to support employers
We look at how big US employers are fostering broader adoption of biosimilar medications and what payers and manufacturers can do to support them.
Report: Partnering And Deal-Making in Pharma through the Pandemic
This Informa report explores how partnering and deal-making in the pharma industry has been impacted by COVID-19.